Read the 10q it says it right in there. To pay for phase 1 clinical trials, daily operations, 7 new isopet clinics, something to do with building a production line for overseas or something along those lines.
The doc is extremely conservative when it comes to the budget,
And yes they will probably have to do another offering but it won’t be until late this year and Or first quarter next year, which by then phase 1 and possibly phase 2 could be completed and they should be able to raise a lot more money for a lot fewer.
Anyone that’s done their research on this knew that they would have to have another offering could they have gotten it a higher price after submitting, possibly. Why take that chance and then not get enough funds to move forward right away with their plans.
News 
Market Data 
Discover 
